| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-01-04 22:31:42 UTC |
|---|
| Update Date | 2022-09-22 18:34:33 UTC |
|---|
| HMDB ID | HMDB0240743 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Indirubin |
|---|
| Description | Indirubin or indigo red is an organic compound with a distinctive deep red/orange color. It is an oxindole dimer consisting of two fused oxindole rings. Indoles are compounds which consist of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. Indirubin is found in both plants and animals and has been detected in human urine and human tissues (PMID: 11076521 ; PMID: 8667928 ). The precursor to indirubin is indican, a colorless, water-soluble derivative of the amino acid tryptophan which is converted to indole via microbial metabolism. Indican readily hydrolyzes to release β-D-glucose and indoxyl. Oxidation of indoxyl by CYP450 enzymes in the liver or kidneys can convert indoxyl to indirubin (PMID: 11076521 ). Likewise, exposure to air can convert indoxyl to indirubin. In addition to the mammalian production of minute amounts of indirubin, this chemical can also be recovered in far larger amounts from plants. Historically, indirubin has been extracted from the leaves of certain plants of the Indigofera genus, in particular Indigofera tinctoria. Indigofera plants were commonly grown and used throughout the world for the production of dyes. Indirubin is a chemical constituent of indigo naturalis (also known as qing dai), which has been used for hundreds of years in traditional Chinese medicine. It is produced by collecting the waste products from the bacterial degradation of specific forms of vegetation. Indirubin has shown anti-inflammatory and anti-angiogenesis properties in vitro (PMID: 21207415 ). It has also been studied for potential use in the treatment of ulcerative colitis (PMID: 23674882 ). |
|---|
| Structure | O=C1NC2=CC=CC=C2\C1=C1/NC2=CC=CC=C2C1=O InChI=1S/C16H10N2O2/c19-15-10-6-2-4-8-12(10)17-14(15)13-9-5-1-3-7-11(9)18-16(13)20/h1-8,17H,(H,18,20)/b14-13+ |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C16H10N2O2 |
|---|
| Average Molecular Weight | 262.268 |
|---|
| Monoisotopic Molecular Weight | 262.07422757 |
|---|
| IUPAC Name | 3-[(2E)-3-oxo-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one |
|---|
| Traditional Name | 3-[(2E)-3-oxo-1H-indol-2-ylidene]-1H-indol-2-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | O=C1NC2=CC=CC=C2\C1=C1/NC2=CC=CC=C2C1=O |
|---|
| InChI Identifier | InChI=1S/C16H10N2O2/c19-15-10-6-2-4-8-12(10)17-14(15)13-9-5-1-3-7-11(9)18-16(13)20/h1-8,17H,(H,18,20)/b14-13+ |
|---|
| InChI Key | CRDNMYFJWFXOCH-BUHFOSPRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as indolines. Indolines are compounds containing an indole moiety, which consists of pyrrolidine ring fused to benzene to form 2,3-dihydroindole. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Indolines |
|---|
| Direct Parent | Indolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dihydroindole
- Aryl ketone
- Benzenoid
- Vinylogous amide
- Amino acid or derivatives
- Carboxamide group
- Ketone
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Enamine
- Secondary amine
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Amine
- Aldehyde
- Organic oxygen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 12.6647 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.14 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2055.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 353.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 124.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 82.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 419.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 746.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 112.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1017.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 398.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1415.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 417.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 368.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 422.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 151.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 130.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Indirubin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 2790.2 | Semi standard non polar | 33892256 | | Indirubin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 2680.6 | Standard non polar | 33892256 | | Indirubin,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 4198.2 | Standard polar | 33892256 | | Indirubin,1TMS,isomer #2 | C[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 2832.1 | Semi standard non polar | 33892256 | | Indirubin,1TMS,isomer #2 | C[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 2685.7 | Standard non polar | 33892256 | | Indirubin,1TMS,isomer #2 | C[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 3772.9 | Standard polar | 33892256 | | Indirubin,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C)C2=CC=CC=C21 | 2597.2 | Semi standard non polar | 33892256 | | Indirubin,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C)C2=CC=CC=C21 | 2654.5 | Standard non polar | 33892256 | | Indirubin,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C)C2=CC=CC=C21 | 3203.0 | Standard polar | 33892256 | | Indirubin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 3043.9 | Semi standard non polar | 33892256 | | Indirubin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 2893.9 | Standard non polar | 33892256 | | Indirubin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2/NC3=CC=CC=C3C2=O)C2=CC=CC=C21 | 4253.3 | Standard polar | 33892256 | | Indirubin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 3102.7 | Semi standard non polar | 33892256 | | Indirubin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 2894.5 | Standard non polar | 33892256 | | Indirubin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1/C(=C2/C(=O)NC3=CC=CC=C23)C(=O)C2=CC=CC=C21 | 3816.5 | Standard polar | 33892256 | | Indirubin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 3113.1 | Semi standard non polar | 33892256 | | Indirubin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 3055.7 | Standard non polar | 33892256 | | Indirubin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)/C(=C2\C(=O)C3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)C2=CC=CC=C21 | 3305.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Indirubin GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-0390000000-410947f1c15dc9a5efb0 | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Indirubin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Indirubin 35V, Positive-QTOF | splash10-03xr-0090000000-5d7a5cde19caf82dc5c4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indirubin 35V, Negative-QTOF | splash10-03di-0090000000-32daf0ba3dd5126dd3c2 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 10V, Positive-QTOF | splash10-03di-0090000000-83721c94bd05c82ff63d | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 20V, Positive-QTOF | splash10-03dj-0490000000-8186d2ad41551d4a3030 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 40V, Positive-QTOF | splash10-001m-1960000000-b339ed52a626d0999bba | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 10V, Negative-QTOF | splash10-01q9-0950000000-d9ae18469cbb0465871c | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 20V, Negative-QTOF | splash10-03ec-4890000000-00c4aebd4b60b9143fca | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 40V, Negative-QTOF | splash10-001i-3490000000-0816fc1ba66f3b255fa0 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 10V, Negative-QTOF | splash10-03di-0090000000-fc429704171183f86ba8 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 20V, Negative-QTOF | splash10-03di-0090000000-fc429704171183f86ba8 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 40V, Negative-QTOF | splash10-001i-0690000000-8edeab68032a2ffd9cce | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 10V, Positive-QTOF | splash10-03di-0090000000-d2ff69a7f2ebf2ad3717 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 20V, Positive-QTOF | splash10-03di-0290000000-3e997be89ac4b2507ce6 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indirubin 40V, Positive-QTOF | splash10-0w30-0690000000-f0409ce01d37892d3205 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Gillam EM, Notley LM, Cai H, De Voss JJ, Guengerich FP: Oxidation of indole by cytochrome P450 enzymes. Biochemistry. 2000 Nov 14;39(45):13817-24. doi: 10.1021/bi001229u. [PubMed:11076521 ]
- Arnold WN: King George III's urine and indigo blue. Lancet. 1996 Jun 29;347(9018):1811-3. doi: 10.1016/s0140-6736(96)91622-0. [PubMed:8667928 ]
- Zhang X, Song Y, Wu Y, Dong Y, Lai L, Zhang J, Lu B, Dai F, He L, Liu M, Yi Z: Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell. Int J Cancer. 2011 Nov 15;129(10):2502-11. doi: 10.1002/ijc.25909. Epub 2011 Apr 7. [PubMed:21207415 ]
- Suzuki H, Kaneko T, Mizokami Y, Narasaka T, Endo S, Matsui H, Yanaka A, Hirayama A, Hyodo I: Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol. 2013 May 7;19(17):2718-22. doi: 10.3748/wjg.v19.i17.2718. [PubMed:23674882 ]
|
|---|